LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights
Abstract Background Cholangiocarcinoma (CHOL) has a poor prognosis due to its asymptomatic progression, challenges in early detection, and limited treatment options. The lncRNA LUCAT1 is highly expressed in several cancers, including lung, gastric, ovarian, and osteosarcoma tissues. Aim This study i...
Saved in:
| Main Authors: | Yuxin An, Qing Chen, Shanshan Zhou, Chengcheng Ying, Guanbao Long, Zouxiao Hu, Jiangyang Sun, Niu Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00512-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR‐539
by: Yongjun Nai, et al.
Published: (2020-01-01) -
FGFR2-Rearrangement in Intrahepatic and Extrahepatic Cholangiocarcinoma and Prognostic Analysis
by: Guo J, et al.
Published: (2025-06-01) -
LINC00313 promotes the aggressiveness and tumorigenesis of cholangiocarcinoma through targeting miR-320b and MITF
by: Ziyu Wang, et al.
Published: (2025-05-01) -
The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients
by: Fatemeh Dayyan, et al.
Published: (2025-05-01) -
Physiogenomics in etiopathogenesis of cholangiocarcinoma
by: Beuy Joob, et al.
Published: (2017-01-01)